Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:810-820

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chancharme, L.
Right arrow Articles by Chapman, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chancharme, L.
Right arrow Articles by Chapman, M. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*COPPER, ELEMENTAL
*LINOLEIC ACID
Related Collections
Right arrow Lipid and lipoprotein metabolism
Right arrow Oxidant stress
Right arrow Risk Factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:810-820.)
© 1999 American Heart Association, Inc.


Original Contributions

Cholesteryl Ester Hydroperoxide Lability Is a Key Feature of the Oxidative Susceptibility of Small, Dense LDL

Laurent Chancharme; Patrice Thérond; Fabienne Nigon; Sylvie Lepage; Martine Couturier; M. John Chapman

From Institut National de la Santé et de la Recherche Médicale (INSERM) U321, Pavillon Benjamin Delessert, Hôpital de la Pitié (L.C., F.N., M.J.C.), Laboratoire de Biochimie "B," Hôpital de la Salpêtrière (S.L.), and Institut Fédératif de Recherche de Physiopathologie et de Génétique Cardiovasculaire, Centre Hospitalo-Universitaire de la Pitié-Salpêtrière (L.C., F.N., S.L., M.J.C.), Paris; and INSERM U347 (P.T., M.C.) and Laboratoire de Biochimie (P.T.), Hôpital de Bicêtre, Bicêtre, France.

Correspondence to Dr M.J. Chapman, INSERM U321, Hôpital de la Pitié, 75651 Paris Cédex 13, France.

Abstract—Abundant evidence has been provided to substantiate the elevated cardiovascular risk associated with small, dense, low density lipoprotein (LDL) particles. The diminished resistance of dense LDL to oxidative stress in both normolipidemic and dyslipidemic subjects is established; nonetheless, the molecular basis of this phenomenon remains indeterminate. We have defined the primary molecular targets of lipid hydroperoxide formation in light, intermediate, and dense subclasses of LDL after copper-mediated oxidation and have compared the relative stabilities of the hydroperoxide derivatives of phospholipids and cholesteryl esters (CEs) as a function of the time course of oxidation. LDL subclasses (LDL1 through LDL5) were isolated from normolipidemic plasma by isopycnic density gradient ultracentrifugation, and their content of polyunsaturated molecular species of phosphatidylcholine (PC) and CE and of lipophilic antioxidants was quantified by reverse-phase high-performance liquid chromatography. The molar ratio of the particle content of polyunsaturated CE and PC species containing linoleate or arachidonate relative to {alpha}-tocopherol or ß-carotene did not differ significantly between LDL subspecies. Nonetheless, dense LDL contained significantly less polyunsaturated CE species (400 mol per particle) compared with LDL1 through LDL4 (range, {approx}680 to 490 mol per particle). Although the formation of PC-derived hydroperoxides did not vary significantly between LDL subspecies as a function of the time course of copper-mediated oxidation, the abundance of the C18:2 and C20:4 CE hydroperoxides was uniquely deficient in dense LDL (23 and 0.6 mol per particle, respectively, in LDL5; 47 to 58 and 1.9 to 2.3 mol per particle, respectively, in other LDL subclasses) at propagation half-time. When expressed as a lability ratio (mol hydroperoxides formed relative to each 100 mol of substrate consumed) at half-time, the oxidative lability of CE hydroperoxides in dense LDL was significantly elevated (lability ratio <25:100) relative to that in lighter, larger LDL particle subclasses (lability ratio >40:100) throughout the oxidative time course. We conclude that the elevated lability of CE hydroperoxides in dense LDL underlies the diminished oxidative resistance of these particles. Moreover, this phenomenon appears to result not only from the significantly elevated PC to free cholesterol ratio (1.54:1) in dense LDL particles (1.15:1 to 1.25:1 for other LDL subclasses) but also from their unique structural features, including a distinct apoB100 conformation, which may facilitate covalent bond formation between oxidized CE and apoB100.


Key Words: LDL subclasses • reversed-phase high-performance liquid chromatography • lipophilic antioxidants • cholesteryl ester hydroperoxides • polyunsaturated fatty acids




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
G. Catalano, E. Duchene, Z. Julia, W. Le Goff, E. Bruckert, M. J. Chapman, and M. Guerin
Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects
J. Lipid Res., March 1, 2008; 49(3): 635 - 643.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
H.-h. Chen, B. D. Hosken, M. Huang, J. W. Gaubatz, C. L. Myers, R. D. Macfarlane, H. J. Pownall, and C.-y. Yang
Electronegative LDLs from familial hypercholesterolemic patients are physicochemically heterogeneous but uniformly proapoptotic
J. Lipid Res., January 1, 2007; 48(1): 177 - 184.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
I. Gazi, E. S. Lourida, T. Filippatos, V. Tsimihodimos, M. Elisaf, and A. D. Tselepis
Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Small, Dense LDL Particles in Human Plasma
Clin. Chem., December 1, 2005; 51(12): 2264 - 2273.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Hansel, P. Giral, E. Nobecourt, S. Chantepie, E. Bruckert, M. J. Chapman, and A. Kontush
Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4963 - 4971.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Pavan, A. Hermouet, V. Tsatsaris, P. Therond, T. Sawamura, D. Evain-Brion, and T. Fournier
Lipids from Oxidized Low-Density Lipoprotein Modulate Human Trophoblast Invasion: Involvement of Nuclear Liver X Receptors
Endocrinology, October 1, 2004; 145(10): 4583 - 4591.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
T. Teerlink, P. G. Scheffer, S. J. L. Bakker, and R. J. Heine
Combined data from LDL composition and size measurement are compatible with a discoid particle shape
J. Lipid Res., May 1, 2004; 45(5): 954 - 966.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Holvoet, S. B. Kritchevsky, R. P. Tracy, A. Mertens, S. M. Rubin, J. Butler, B. Goodpaster, and T. B. Harris
The Metabolic Syndrome, Circulating Oxidized LDL, and Risk of Myocardial Infarction in Well-Functioning Elderly People in the Health, Aging, and Body Composition Cohort
Diabetes, April 1, 2004; 53(4): 1068 - 1073.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Kontush, E. C. de Faria, S. Chantepie, and M. J. Chapman
Antioxidative Activity of HDL Particle Subspecies Is Impaired in Hyperalphalipoproteinemia: Relevance of Enzymatic and Physicochemical Properties
Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 526 - 533.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Kontush, S. Chantepie, and M. J. Chapman
Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress
Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1881 - 1888.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Holvoet, T. B. Harris, R. P. Tracy, P. Verhamme, A. B. Newman, S. M. Rubin, E. M. Simonsick, L. H. Colbert, and S. B. Kritchevsky
Association of High Coronary Heart Disease Risk Status With Circulating Oxidized LDL in the Well-Functioning Elderly: Findings From the Health, Aging, and Body Composition Study
Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1444 - 1448.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. T. Williams, H. R. Superko, W. L. Haskell, E. L. Alderman, P. J. Blanche, L. G. Holl, and R. M. Krauss
Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men
Arterioscler. Thromb. Vasc. Biol., February 14, 2003; 23(2): 314 - 321.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. C. Sposito and M. J. Chapman
Statin Therapy in Acute Coronary Syndromes: Mechanistic Insight Into Clinical Benefit
Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1524 - 1534.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Chancharme, P. Therond, F. Nigon, S. Zarev, A. Mallet, E. Bruckert, and M. J. Chapman
LDL particle subclasses in hypercholesterolemia: molecular determinants of reduced lipid hydroperoxide stability
J. Lipid Res., March 1, 2002; 43(3): 453 - 462.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
V. Tsimihodimos, S.-A. P. Karabina, A. P. Tambaki, E. Bairaktari, G. Miltiadous, J. A. Goudevenos, M. A. Cariolou, M. J. Chapman, A. D. Tselepis, and M. Elisaf
Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia
J. Lipid Res., February 1, 2002; 43(2): 256 - 263.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. Lepage, F. Nigon, D. Bonnefont-Rousselot, U. Assogba, S. Goulinet, L. Chancharme, J. Delattre, E. Bruckert, and M. J. Chapman
Oxidizability of Atherogenic Low-Density Lipoprotein Subspecies in Severe Familial Hypercholesterolemia: Impact of Long-Term Low-Density Lipoprotein Apheresis
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(2): 87 - 103.
[Abstract] [PDF]